Literature DB >> 26858255

Central Role of Pyruvate Kinase in Carbon Co-catabolism of Mycobacterium tuberculosis.

Tahel Noy1, Olivia Vergnolle1, Travis E Hartman2, Kyu Y Rhee2, William R Jacobs3, Michael Berney4, John S Blanchard5.   

Abstract

Mycobacterium tuberculosis (Mtb) displays a high degree of metabolic plasticity to adapt to challenging host environments. Genetic evidence suggests thatMtbrelies mainly on fatty acid catabolism in the host. However,Mtbalso maintains a functional glycolytic pathway and its role in the cellular metabolism ofMtbhas yet to be understood. Pyruvate kinase catalyzes the last and rate-limiting step in glycolysis and theMtbgenome harbors one putative pyruvate kinase (pykA, Rv1617). Here we show thatpykAencodes an active pyruvate kinase that is allosterically activated by glucose 6-phosphate (Glc-6-P) and adenosine monophosphate (AMP). Deletion ofpykApreventsMtbgrowth in the presence of fermentable carbon sources and has a cidal effect in the presence of glucose that correlates with elevated levels of the toxic catabolite methylglyoxal. Growth attenuation was also observed in media containing a combination of short chain fatty acids and glucose and surprisingly, in media containing odd and even chain fatty acids alone. Untargeted high sensitivity metabolomics revealed that inactivation of pyruvate kinase leads to accumulation of phosphoenolpyruvate (P-enolpyruvate), citrate, and aconitate, which was consistent with allosteric inhibition of isocitrate dehydrogenase by P-enolpyruvate. This metabolic block could be relieved by addition of the α-ketoglutarate precursor glutamate. Taken together, our study identifies an essential role of pyruvate kinase in preventing metabolic block during carbon co-catabolism inMtb.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Mycobacterium tuberculosis; allosteric regulation; bacterial metabolism; fatty acid metabolism; microbial pathogenesis; pyruvate kinase; tricarboxylic acid cycle (TCA cycle) (Krebs cycle)

Mesh:

Substances:

Year:  2016        PMID: 26858255      PMCID: PMC4807288          DOI: 10.1074/jbc.M115.707430

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Effect of growth rate reduction and genetic modifications on acetate accumulation and biomass yields in Escherichia coli.

Authors:  E Ponce
Journal:  J Biosci Bioeng       Date:  1999       Impact factor: 2.894

Review 2.  Protective mechanisms against toxic electrophiles in Escherischia coli.

Authors:  G P Ferguson
Journal:  Trends Microbiol       Date:  1999-06       Impact factor: 17.079

3.  Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.

Authors:  Roya Zoraghi; Raymond H See; Peter Axerio-Cilies; Nag S Kumar; Huansheng Gong; Anne Moreau; Michael Hsing; Sukhbir Kaur; Richard D Swayze; Liam Worrall; Emily Amandoron; Tian Lian; Linda Jackson; Jihong Jiang; Lisa Thorson; Christophe Labriere; Leonard Foster; Robert C Brunham; William R McMaster; B Brett Finlay; Natalie C Strynadka; Artem Cherkasov; Robert N Young; Neil E Reiner
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

4.  Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux.

Authors:  Qijun Wang; Yakun Zhang; Chen Yang; Hui Xiong; Yan Lin; Jun Yao; Hong Li; Lu Xie; Wei Zhao; Yufeng Yao; Zhi-Bin Ning; Rong Zeng; Yue Xiong; Kun-Liang Guan; Shimin Zhao; Guo-Ping Zhao
Journal:  Science       Date:  2010-02-19       Impact factor: 47.728

5.  Global effects of inactivation of the pyruvate kinase gene in the Mycobacterium tuberculosis complex.

Authors:  Sivagamisundaram Chavadi; Esen Wooff; Nicholas G Coldham; Manjula Sritharan; R Glyn Hewinson; Stephen V Gordon; Paul R Wheeler
Journal:  J Bacteriol       Date:  2009-10-09       Impact factor: 3.490

Review 6.  Bacterial production of methylglyoxal: a survival strategy or death by misadventure?

Authors:  I R Booth; G P Ferguson; S Miller; C Li; B Gunasekera; S Kinghorn
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

7.  Studies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosis.

Authors:  Katherine C Yam; Igor D'Angelo; Rainer Kalscheuer; Haizhong Zhu; Jian-Xin Wang; Victor Snieckus; Lan H Ly; Paul J Converse; William R Jacobs; Natalie Strynadka; Lindsay D Eltis
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

8.  Characterization of phosphofructokinase activity in Mycobacterium tuberculosis reveals that a functional glycolytic carbon flow is necessary to limit the accumulation of toxic metabolic intermediates under hypoxia.

Authors:  Wai Yee Phong; Wenwei Lin; Srinivasa P S Rao; Thomas Dick; Sylvie Alonso; Kevin Pethe
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

9.  Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.

Authors:  Dimitrios Anastasiou; Yimin Yu; William J Israelsen; Jian-Kang Jiang; Matthew B Boxer; Bum Soo Hong; Wolfram Tempel; Svetoslav Dimov; Min Shen; Abhishek Jha; Hua Yang; Katherine R Mattaini; Christian M Metallo; Brian P Fiske; Kevin D Courtney; Scott Malstrom; Tahsin M Khan; Charles Kung; Amanda P Skoumbourdis; Henrike Veith; Noel Southall; Martin J Walsh; Kyle R Brimacombe; William Leister; Sophia Y Lunt; Zachary R Johnson; Katharine E Yen; Kaiko Kunii; Shawn M Davidson; Heather R Christofk; Christopher P Austin; James Inglese; Marian H Harris; John M Asara; Gregory Stephanopoulos; Francesco G Salituro; Shengfang Jin; Lenny Dang; Douglas S Auld; Hee-Won Park; Lewis C Cantley; Craig J Thomas; Matthew G Vander Heiden
Journal:  Nat Chem Biol       Date:  2012-10       Impact factor: 15.040

10.  Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosis.

Authors:  Paras Jain; Tsungda Hsu; Masayoshi Arai; Karolin Biermann; David S Thaler; Andrew Nguyen; Pablo A González; Joann M Tufariello; Jordan Kriakov; Bing Chen; Michelle H Larsen; William R Jacobs
Journal:  MBio       Date:  2014-06-03       Impact factor: 7.867

View more
  15 in total

Review 1.  Mycobacterium tuberculosis in the Face of Host-Imposed Nutrient Limitation.

Authors:  Michael Berney; Linda Berney-Meyer
Journal:  Microbiol Spectr       Date:  2017-06

2.  PPE37 Is Essential for Mycobacterium tuberculosis Heme-Iron Acquisition (HIA), and a Defective PPE37 in Mycobacterium bovis BCG Prevents HIA.

Authors:  Michael V Tullius; Susana Nava; Marcus A Horwitz
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

3.  Model-based integration of genomics and metabolomics reveals SNP functionality in Mycobacterium tuberculosis.

Authors:  Ove Øyås; Sonia Borrell; Andrej Trauner; Michael Zimmermann; Julia Feldmann; Thomas Liphardt; Sebastien Gagneux; Jörg Stelling; Uwe Sauer; Mattia Zampieri
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-30       Impact factor: 11.205

Review 4.  Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis.

Authors:  Sabine Ehrt; Dirk Schnappinger; Kyu Y Rhee
Journal:  Nat Rev Microbiol       Date:  2018-08       Impact factor: 60.633

5.  Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824).

Authors:  Rafael Baptista; David M Fazakerley; Manfred Beckmann; Les Baillie; Luis A J Mur
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

6.  Glutamate mediated metabolic neutralization mitigates propionate toxicity in intracellular Mycobacterium tuberculosis.

Authors:  Jae Jin Lee; Juhyeon Lim; Shengjia Gao; Christopher P Lawson; Mark Odell; Saki Raheem; JeongIm Woo; Sung-Ho Kang; Shin-Seok Kang; Bo-Young Jeon; Hyungjin Eoh
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

7.  Allosteric pyruvate kinase-based "logic gate" synergistically senses energy and sugar levels in Mycobacterium tuberculosis.

Authors:  Wenhe Zhong; Liang Cui; Boon Chong Goh; Qixu Cai; Peiying Ho; Yok Hian Chionh; Meng Yuan; Abbas El Sahili; Linda A Fothergill-Gilmore; Malcolm D Walkinshaw; Julien Lescar; Peter C Dedon
Journal:  Nat Commun       Date:  2017-12-07       Impact factor: 14.919

8.  Metabolic adaptation of two in silico mutants of Mycobacterium tuberculosis during infection.

Authors:  Víctor A López-Agudelo; Andres Baena; Howard Ramirez-Malule; Silvia Ochoa; Luis F Barrera; Rigoberto Ríos-Estepa
Journal:  BMC Syst Biol       Date:  2017-11-21

9.  Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.

Authors:  Nicole C Howard; Nancy D Marin; Mushtaq Ahmed; Bruce A Rosa; John Martin; Monika Bambouskova; Alexey Sergushichev; Ekaterina Loginicheva; Natalia Kurepina; Javier Rangel-Moreno; Liang Chen; Barry N Kreiswirth; Robyn S Klein; Joan-Miquel Balada-Llasat; Jordi B Torrelles; Gaya K Amarasinghe; Makedonka Mitreva; Maxim N Artyomov; Fong-Fu Hsu; Barun Mathema; Shabaana A Khader
Journal:  Nat Microbiol       Date:  2018-09-17       Impact factor: 17.745

10.  Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection.

Authors:  Erik J Hasenoehrl; Dannah Rae Sajorda; Linda Berney-Meyer; Samantha Johnson; JoAnn M Tufariello; Tobias Fuhrer; Gregory M Cook; William R Jacobs; Michael Berney
Journal:  Nat Commun       Date:  2019-09-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.